Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Weighing benefits and risks--the FDA's review of prasugrel.

× No keyword cloud information.

18 in total

1. Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.

Authors: Yi-Ling Hsieh; Jeremy M Merritt; Weili Yu; Lynne S Taylor
Journal: Pharm Res Date: 2015-04-15 Impact factor: 4.200

2. In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report.

Authors: Tarun Nagrani; Medhat Zaher; Sainath Gaddam; George Jabbour; Duccio Baldari; Roberto Baglini; Srinivas Duvvuri
Journal: Cases J Date: 2010-02-23

3. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal: Chest Date: 2012-02 Impact factor: 9.410

4. Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Authors: Sampada Koranne; Seema Thakral; Raj Suryanarayanan
Journal: Pharm Res Date: 2018-01-05 Impact factor: 4.200

Review 5. Novel treatments for cardiovascular disease prevention.

Authors: Mark D Huffman; Deepak Bhatnagar
Journal: Cardiovasc Ther Date: 2011-05-31 Impact factor: 3.023

6. Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.

Authors: Yi-Ling Hsieh; Lynne S Taylor
Journal: Pharm Res Date: 2014-08-22 Impact factor: 4.200

7. Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Authors: Matthew T Roe; Derek D Cyr; Debra Eckart; Phillip J Schulte; Michael A Morse; Kimberly L Blackwell; Neal E Ready; S Yousuf Zafar; Anne W Beaven; John H Strickler; Jane E Onken; Kenneth J Winters; Lisa Houterloot; Dmitry Zamoryakhin; Stephen D Wiviott; Harvey D White; Dorairaj Prabhakaran; Keith A A Fox; Paul W Armstrong; E Magnus Ohman
Journal: Eur Heart J Date: 2015-12-05 Impact factor: 29.983

8. Causes of late mortality with dual antiplatelet therapy after coronary stents.

Authors: Laura Mauri; Sammy Elmariah; Robert W Yeh; Donald E Cutlip; P Gabriel Steg; Stephan Windecker; Stephen D Wiviott; David J Cohen; Joseph M Massaro; Ralph B D'Agostino; Eugene Braunwald; Dean J Kereiakes
Journal: Eur Heart J Date: 2015-11-18 Impact factor: 29.983

Review 9. TRITON and beyond: new insights into the profile of prasugrel.

Authors: Joseph A Jakubowski; Jeffrey S Riesmeyer; Sandra L Close; Amy G Leishman; David Erlinge
Journal: Cardiovasc Ther Date: 2011-02-17 Impact factor: 3.023

Review 10. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review.

Authors: Kazem Rahimi; Aneil Malhotra; Adrian P Banning; Crispin Jenkinson
Journal: BMJ Date: 2010-11-01